Search Results - "Lau, Wan Yee"

Recommendations for management of patients with neuroendocrine liver metastases by Frilling, Andrea, Prof, Modlin, Irvin M, Prof, Kidd, Mark, PhD, Russell, Christopher, Prof, Breitenstein, Stefan, MD, Salem, Riad, Prof, Kwekkeboom, Dik, MD, Lau, Wan-yee, Prof, Klersy, Catherine, MD, Vilgrain, Valerie, Prof, Davidson, Brian, Prof, Siegler, Mark, Prof, Caplin, Martyn, Prof, Solcia, Enrico, Prof, Schilsky, Richard, Prof

“…Summary Many management strategies exist for neuroendocrine liver metastases. These strategies range from surgery to ablation with various interventional…”
Get full text

Techniques for Abdominal Wall Closure after Damage Control Laparotomy: From Temporary Abdominal Closure to Early/Delayed Fascial Closure—A Review by Huang, Qian, Lau, Wan-yee, Li, Jieshou

“…Open abdomen (OA) has been an effective treatment for abdominal catastrophes in traumatic and general surgery. However, management of patients with OA remains…”
Get full text

A new classification for hepatocellular carcinoma with portal vein tumor thrombus by Shi, Jie, Lai, Eric C. H., Li, Nan, Guo, Wei-Xing, Xue, Jie, Lau, Wan-Yee, Wu, Meng-Chao, Cheng, Shu-Qun

“…Background/purpose We aimed to correlate the survival of patients with hepatocellular carcinoma (HCC) with macroscopic portal vein tumor thrombus (PVTT) who…”
Get full text

Hepatocellular carcinoma: current management and recent advances by Lau, Wan-Yee, Lai, Eric C H

“…BACKGROUND: Hepatocellular carcinoma (HCC) is a major health problem worldwide. It is the fifth most common cancer in the world, and the third most common…”
Get full text

Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009 by Poon, Donald, Dr, Anderson, Benjamin O, Prof, Chen, Li-Tzong, MD, Tanaka, Koichi, Prof, Lau, Wan Yee, Prof, Van Cutsem, Eric, Prof, Singh, Harjit, MD, Chow, Wan Cheng, Prof, Ooi, London Lucien, Prof, Chow, Pierce, MD, Khin, Maung Win, Prof, Koo, Wen Hsin, MD

“…Summary Asia has a disproportionately large share of the world's hepatocellular carcinoma (HCC), mainly because of the endemic status of chronic hepatitis B…”
Get full text

TG13 current terminology, etiology, and epidemiology of acute cholangitis and cholecystitis by Kimura, Yasutoshi, Takada, Tadahiro, Strasberg, Steven M., Pitt, Henry A., Gouma, Dirk J., Garden, O. James, Büchler, Markus W., Windsor, John A., Mayumi, Toshihiko, Yoshida, Masahiro, Miura, Fumihiko, Higuchi, Ryota, Gabata, Toshifumi, Hata, Jiro, Gomi, Harumi, Dervenis, Christos, Lau, Wan-Yee, Belli, Giulio, Kim, Myung-Hwan, Hilvano, Serafin C., Yamashita, Yuichi

“…While referring to the evidence adopted in the Tokyo Guidelines 2007 (TG07) as well as subsequently obtained evidence, further discussion took place on…”
Get full text

Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients by Xia, Feng, Wu, Li-Li, Lau, Wan-Yee, Huan, Hong-Bo, Wen, Xu-Dong, Ma, Kuan-Sheng, Li, Xiao-Wu, Bie, Ping

“…AIM: To investigate the efficacy and safety of adjuvant sorafenib after curative resection for patients with Barcelona Clinic Liver Cancer(BCLC)-stage C…”
Get full text

TG13 diagnostic criteria and severity grading of acute cholecystitis (with videos) by Yokoe, Masamichi, Takada, Tadahiro, Strasberg, Steven M., Solomkin, Joseph S., Mayumi, Toshihiko, Gomi, Harumi, Pitt, Henry A., Garden, O. James, Kiriyama, Seiki, Hata, Jiro, Gabata, Toshifumi, Yoshida, Masahiro, Miura, Fumihiko, Okamoto, Kohji, Tsuyuguchi, Toshio, Itoi, Takao, Yamashita, Yuichi, Dervenis, Christos, Chan, Angus C.W., Lau, Wan-Yee, Supe, Avinash N., Belli, Giulio, Hilvano, Serafin C., Liau, Kui-Hin, Kim, Myung-Hwan, Kim, Sun-Whe, Ker, Chen-Guo

“…Since its publication in 2007, the Tokyo Guidelines for the management of acute cholangitis and cholecystitis (TG07) have been widely adopted. The validation…”
Get full text

Patient Selection and Activity Planning Guide for Selective Internal Radiotherapy With Yttrium-90 Resin Microspheres by Lau, Wan-Yee, M.D, Kennedy, Andrew S., M.D., F.A.C.R.O, Kim, Yun Hwan, M.D., Ph.D, Lai, Hee Kit, M.B., B.Ch., M.R.C.P. (UK), F.A.M.S. (Singapore), Lee, Rheun-Chuan, M.D, Leung, Thomas W.T., M.D, Liu, Ching-Sheng, Ph.D, Salem, Riad, M.D., M.B.A, Sangro, Bruno, M.D., Ph.D, Shuter, Borys, M.D, Wang, Shih-Chang, M.B., B.S., B.Sc (Med.)., F.R.A.N.Z.C.R., F.A.M.S

“…Purpose Selective internal radiotherapy (SIRT) with yttrium-90 (90 Y) resin microspheres can improve the clinical outcomes for selected patients with…”
Get full text

Portal vein tumor thrombus is a bottleneck in the treatment of hepatocellular carcinoma by Sun, Ju-Xian, Shi, Jie, Li, Nan, Guo, Wei-Xing, Wu, Meng-Chao, Lau, Wan-Yee, Cheng, Shu-Qun

“…The effect of portal vein tumor thrombus（PVTT） on the prognosis of patients with hepatocellular carcinoma has become clear over the past several decades…”
Get full text

An artificial neural networking model for the prediction of post-hepatectomy survival of patients with early hepatocellular carcinoma by Qiao, Guoliang, Li, Jun, Huang, Aiming, Yan, Zhenlin, Lau, Wan-Yee, Shen, Feng

“…Background and Aims This study aimed to establish a prognostic artificial neural network model (ANN) for early hepatocellular carcinoma (HCC) following partial…”
Get full text

Causes of peripheral cytopenia in hepatitic cirrhosis and portal hypertensive splenomegaly by Lv, Yunfu, Yee Lau, Wan, Wu, Hongfei, Han, XiaoYu, Gong, Xiaoguang, Liu, Ning, Yue, Jie, Li, Qingqing, Li, YeJuan, Deng, Jie

“…The clinical data of 183 patients with hepatitic cirrhosis and portal hypertensive splenomegaly complicated by peripheral cytopenia were retrospectively…”
Get full text

Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis by Xing, Hao, Zheng, Yi-Jie, Han, Jun, Zhang, Han, Li, Zhen-Li, Lau, Wan-Yee, Shen, Feng, Yang, Tian

“…As a promising biomarker of hepatocellular carcinoma (HCC), protein induced by vitamin K absence or antagonist-II (PIVKA-II) has been studied extensively…”
Get full text

Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis by Xia, Feng, Wu, Lin, Lau, Wan-Yee, Li, Guo, Huan, Hongbo, Qian, Cheng, Ma, Kuansheng, Bie, Ping

“…The prognosis of hepatocellular carcinoma (HCC) patients with extrahepatic metastasis is extremely poor. However, what is the main risk factor for survival…”
Get full text

Synthetic miR-26a mimics delivered by tumor exosomes repress hepatocellular carcinoma through downregulating lymphoid enhancer factor 1 by Hu, Jie, Liu, Wei-Feng, Zhang, Xiang-Yu, Shi, Guo-Ming, Yang, Xin-Rong, Zhou, Kai-Qian, Hu, Bo, Chen, Fei-Yu, Zhou, Cheng, Lau, Wan-Yee, Fan, Jia, Wang, Zheng, Zhou, Jian

“…Background The dysregulation of exosomal microRNAs plays an important role in the progression of hepatocarcinogenesis. In this study, we investigated the…”
Get full text

Determination of Clonal Origin of Recurrent Hepatocellular Carcinoma for Personalized Therapy and Outcomes Evaluation: A New Strategy for Hepatic Surgery by Wang, Bin, MD, PhD, Xia, Chun-Yan, MD, PhD, Lau, Wan-Yee, MD, PhD, Lu, Xin-Yuan, MD, Dong, Hui, MD, PhD, Yu, Wen-Long, MD, PhD, Jin, Guang-Zhi, PhD, Cong, Wen-Ming, MD, PhD, Wu, Meng-Chao, MD

“…Background Recurrent hepatocellular carcinoma (RHCC) after curative resection is a major challenge for hepatic surgeons. A better understanding of the clonal…”
Get full text

Mesohepatectomy for centrally located large hepatocellular carcinoma: Indications, techniques, and outcomes by Yang, Lian-Yue, MD, PhD, FACS, Chang, Rui-Min, MD, Lau, Wan-Yee, MD, Hon FRACS, Ou, Di-Peng, MD, Wu, Wei, MD, Zeng, Zhi-Jun, MD

“…Background Whether mesohepatectomy should be performed for large hepatocellular carcinoma (HCC) located in the central part of the liver is controversial, and…”
Get full text

Adjuvant Sorafenib Following Radiofrequency Ablation for Early-Stage Recurrent Hepatocellular Carcinoma With Microvascular Invasion at the Initial Hepatectomy by Wei, Meng-Chao, Zhang, Yao-Jun, Chen, Min-Shan, Chen, Yong, Lau, Wan-Yee, Peng, Zhen-Wei

“…Background The efficacy of radiofrequency ablation (RFA) for patients with early-stage recurrent hepatocellular carcinoma (HCC) with microvascular invasion…”
Get full text

Does Hepatic Ischemia–Reperfusion Injury Induced by Hepatic Pedicle Clamping Affect Survival after Partial Hepatectomy for Hepatocellular Carcinoma? by Xia, Feng, Lau, Wan-Yee, Xu, Yanmin, Wu, Lin, Qian, Cheng, Bie, Ping

“…Background Liver resection offers a chance of cure for patients with hepatocellular carcinoma (HCC). Hepatic pedicle clamping (HPC) is commonly used to reduce…”
Get full text

Comparison of hydrochloric acid infusion radiofrequency ablation with microwave ablation in an ex vivo liver model by Deng, Hanxia, Zhang, Tianqi, Jiang, Xiongying, Huang, Senmiao, Jiang, Nan Nancy, Lau, Wan-Yee, Jinhua, Huang

“…To compare sizes and shapes of ablation zones resulting from hydrochloric acid infusion radiofrequency ablation (HRFA) and microwave ablation (MWA), using…”
Get full text